{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:58:04Z","timestamp":1770814684567,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.forsciint.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T20:51:31Z","timestamp":1558126291000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3082-4532","authenticated-orcid":false,"given":"Francesco Paolo","family":"Busard\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annagiulia","family":"Di Trana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Mauloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriano","family":"Tagliabracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Giorgetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2019.05.018_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1185\/03007998909112670","article-title":"Etizolam in the treatment of generalized anxiety disorder associated with depressive symptom","volume":"9","author":"Parinte","year":"1989","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1185\/03007999009111650","article-title":"Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo","volume":"12","author":"Casacchia","year":"1990","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0015","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00228-005-0032-8","article-title":"Pharmacokinetics and Pharmacodynamics of etizolam and injfluenced by polymorphic CYP2C19 activity","volume":"11","author":"Fukasawa","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0020","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00228-004-0789-1","article-title":"Inibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism","volume":"60","author":"Araki","year":"2004","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17425255.2013.759209","article-title":"Understanding pharmacokinetics of anxiolytic drugs","volume":"9","author":"Altamura","year":"2013","journal-title":"Opin. Drug Toxicol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0030","first-page":"181","article-title":"Single and multiple dose pharmacokinetics of etizolam in healthy subjects","volume":"40","author":"Fracasso","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0035","first-page":"88","article-title":"Molecular and neurochimical evaluation of the effects of etizolam on GABAa receptors under normal and stress condition","volume":"49","author":"Sanna","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.forsciint.2019.05.018_bib0040","first-page":"3","article-title":"Low tolerance and dependence liabilities of etizolam: molecular, fuctional, and pharmacological correlate","volume":"519","author":"Sanna","year":"2005","journal-title":"Eur. J. Clin. Pharamcol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.2003.019869","article-title":"Etizolam and benzodiazepine induced blepharospasm","volume":"75","author":"Wakakura","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.forsciint.2019.05.018_bib0050","first-page":"121","article-title":"A successful case of dose reduction in etizolam dependence using fine granules: a case report","volume":"7","author":"Nishii","year":"2014","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4103\/0253-7613.144943","article-title":"A case of etizolam dependence","volume":"46","author":"Gupta","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0060","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0065","first-page":"38","article-title":"An autopsy case of multiple psychotropic drug poisoning","volume":"56","author":"Tanaka","year":"2011","journal-title":"Soud. Lek."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jat\/bkw012","article-title":"Analysis of MT-45, a novel synthetic opioid, in human whole blood by LC-MS-MS and its identification in a drug-related death","volume":"40","author":"Papsun","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0075","unstructured":"National Records of Scotland. www.nrscotland.gov.uk\/statistics-and-data\/statistics\/statistics-by-theme\/vital-events\/deaths\/drug-related-deaths-in-scotland\/2014.last. (Accessed 21 November 2018)."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.08.012","article-title":"Case report: etizolam and its major metabolites in two unnatural death cases","volume":"182","author":"Nakamae","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0085","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1360-0443.2008.02277.x","article-title":"Guidelines for research on drugged driving","volume":"103","author":"Walsh","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2019.05.018_bib0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s002280050560","article-title":"Effects of single dose of gamma-hydroxybutyric acid and lorazepam on psychomotor performance and subjective feelings in healthy volunteers","volume":"54","author":"Ferrara","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0095","doi-asserted-by":"crossref","first-page":"s62","DOI":"10.1007\/BF02246238","article-title":"Effect of meclobemide and mianserin on highway driving, psychometric performance and subjective parameters relative to placebo","volume":"106","author":"Ramaerkers","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.forsciint.2019.05.018_bib0100","first-page":"135","article-title":"La fr\u00e9quence de fusion optique subjective: comparaison de trois m\u00e9thodes de mesure avant et apr\u00e8s le travail","volume":"26","author":"Rey","year":"1964","journal-title":"Trav. Hum."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0105","first-page":"421","article-title":"Memory scanning: mental processes revealed by reaction time experiments","volume":"57","author":"Sternberg","year":"1969","journal-title":"Am. Sci."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0110","first-page":"363","article-title":"Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving","volume":"42","author":"Ramaerkers","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3758\/BF03203267","article-title":"Effects of noise letters on the identification of a target letter in a nonsearch task","volume":"16","author":"Eriksen","year":"1974","journal-title":"Percept. Psychophys."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0120","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.6836276","article-title":"Visual sustained attention: image degradation produces rapid sensitivity decrement over time","volume":"220","author":"Neuchterlein","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.forsciint.2019.05.018_bib0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0924-977X(94)00130-4","article-title":"Acute and subchronic effects on psychomotor of paroxetine 20 and 40 mg on actual driving, psychomotor performances and subjective assessments in healthy volunteers","volume":"5","author":"Robbe","year":"1995","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3758\/BF03342823","article-title":"A non-parametric analysis of recognition experiments","volume":"1","author":"Pollack","year":"1964","journal-title":"Psychon. Sci."},{"key":"10.1016\/j.forsciint.2019.05.018_bib0135","series-title":"Statistical Principles in Experimental Design","author":"Wiener","year":"1962"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819302038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819302038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T06:14:31Z","timestamp":1561702471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073819302038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":27,"alternative-id":["S0379073819302038"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.05.018","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}